By: Kemahl Franklyn The U.S. Department of Justice (DOJ) and a bipartisan multistate coalition have filed lawsuits this year against Live Nation Entertainment — the parent company of Ticketmaster...
Current distributions, also known as non-liquidating distributions, are critical to a partnership's or limited liability company’s (LLC) operations since pass-through entities use current distributions...
Perfluorinated and Polyfluorinated Substances (PFAS) are found in many consumer products such as cookware, food packaging, cosmetics, and stain repellants, and can be released into the air, soil, and water...
Navigating the intricate world of private company transactions requires a keen understanding of the key negotiating points that can make or break the deal. This checklist provides a general outline of...
Understand how to prepare and submit a request to the FDA asking it to review critical elements of a protocol design. Read now » Related Content FDA Drug Regulatory Activity Tracker Follow...
FTC Chair Lina Khan told a conference of the American Medical Association on February 14, 2024, that the healthcare market is under the microscope in the Commission’s push for greater competition across the economy. Recent efforts by the FTC in this space include requesting public comment on how powerful “middlemen” in the generic drug market may contribute to shortages of these drugs. The agency also announced a March 5 virtual workshop to examine the role of private equity’s investment in healthcare markets. Additionally, the FTC issued a recent comment supporting the government’s right to “march in” to invalidate a patent if the patent holder is charging an excessive price on a patented drug developed with taxpayer-funded research.
The Antitrust Agency Developments Tracker covers these developments and other FTC and DOJ non-case-related efforts, policy statements, and goings-on at the agencies.
READ NOW »
Related Content
Practical Guidance Updates Featuring the latest updates from your Practical Guidance account.
PRACTICAL GUIDANCE CUSTOMER EMAIL EDITION ON THE WEB
Experience results today with practical guidance, legal research, and data-driven insights—all in one place.Experience Lexis+